Esteve Ribera

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine.

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine.

Journal: The Journal of antimicrobial chemotherapy
Published: November 22, 2023

eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort.

eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort.

Journal: HIV research & clinical practice
Published: August 19, 2021

Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.

Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.

Journal: The lancet. HIV
Published: December 24, 2020

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

Journal: The Journal of antimicrobial chemotherapy
Published: August 20, 2020

Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow up.

Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow up.

Journal: HIV research & clinical practice
Published: February 18, 2020

Brief Report: Effectiveness of Trichloroacetic Acid vs. Electrocautery Ablation for the Treatment of Anal High-Grade Squamous Intraepithelial Lesion in HIV-Infected Patients.

Brief Report: Effectiveness of Trichloroacetic Acid vs. Electrocautery Ablation for the Treatment of Anal High-Grade Squamous Intraepithelial Lesion in HIV-Infected Patients.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 05, 2018

The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.

The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.

Journal: AIDS (London, England)
Published: July 21, 2017

Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.

Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.

Journal: PloS one
Published: June 26, 2015

Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM.

Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM.

Journal: AIDS (London, England)
Published: April 08, 2015

Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature.

Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature.

Journal: Medicine
Published: March 28, 2015

Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.

Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.

Journal: The American journal of tropical medicine and hygiene
Published: March 20, 2013

Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.

Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.

Journal: The Journal of antimicrobial chemotherapy
Published: June 26, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026